| Date Filed | Type | Description |
| 10/13/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/12/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/11/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/10/2023 |
4
| Auwaerter Paul Gisbert (Director) has filed a Form 4 on CAPRICOR THERAPEUTICS, INC.|
Txns:
| Bought 5,000 shares
@ $2.84, valued at
$14.2k
|
|
| 10/06/2023 |
4
| Musket David B (Director) has filed a Form 4 on CAPRICOR THERAPEUTICS, INC.|
Txns:
| Bought 2,500 shares
@ $2.9, valued at
$7.3k
|
|
| 09/29/2023 |
424B5
| Form 424B5 - Prospectus [Rule 424(b)(5)]: |
| 09/29/2023 |
8-K
| Entry into a Material Definitive Agreement, Regulation FD Disclosure, Financial Statements and Exhibits Inte... |
| 09/29/2023 |
FWP
| Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses: |
| 09/29/2023 |
8-K
| Quarterly results |
| 08/16/2023 |
4
| Litvack Frank (Director) has filed a Form 4 on CAPRICOR THERAPEUTICS, INC.|
Txns:
| Exercised 20,748 shares
@ $1.39, valued at
$28.8k
Paid exercise price by delivering 4,364 shares
@ $6.61, valued at
$28.8k
Exercised 20,748 options to buy
@ $0 |
|
| 08/08/2023 |
10-Q
| Quarterly Report for the period ended June 30, 2023 |
| 08/07/2023 |
8-K
| Quarterly results |
| 07/24/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/24/2023 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 07/24/2023 |
8-K
| Quarterly results |
| 07/13/2023 |
4
| Auwaerter Paul Gisbert (Director) has filed a Form 4 on CAPRICOR THERAPEUTICS, INC.|
Txns:
| Granted 115,000 options to buy
@ $4.47, valued at
$514.1k
|
|
| 07/13/2023 |
3
| Auwaerter Paul Gisbert (Director) has filed a Form 3 on CAPRICOR THERAPEUTICS, INC. |
| 07/13/2023 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 06/15/2023 |
8-K/A
| Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits ... |
| 06/15/2023 |
8-K/A
| Submission of Matters to a Vote of Security Holders Interactive Data |
| 05/16/2023 |
4
| Marban Linda (CEO) has filed a Form 4 on CAPRICOR THERAPEUTICS, INC.|
Txns:
| Exercised 41,497 options to buy
@ $1.39, valued at
$57.7k
|
|
| 05/12/2023 |
10-Q
| Quarterly Report for the period ended March 31, 2023 |
| 05/11/2023 |
8-K
| Quarterly results |
| 04/27/2023 |
4
| Avat Xavier (Former CBO) has filed a Form 4 on CAPRICOR THERAPEUTICS, INC.|
Txns:
| Sold 14,772 shares
@ $64258, valued at
$949.2M
|
|
| 04/21/2023 |
ARS
| Form ARS - Annual Report to Security Holders: |
| 04/17/2023 |
DEF 14A
| Form DEF 14A - Other definitive proxy statements: |
| 03/17/2023 |
10-K
| Annual Report for the period ended December 31, 2022 |
| 03/15/2023 |
8-K
| Results of Operations and Financial Condition, Financial Statements and Exhibits Interactive Data |
| 02/23/2023 |
4
| Manzo Louis (Director) has filed a Form 4 on CAPRICOR THERAPEUTICS, INC.|
Txns:
| Exercised 1,401 shares
@ $1.39, valued at
$1.9k
Disposed/sold 452 shares
@ $4.31, valued at
$1.9k
Exercised 1,401 options to buy
@ $0 |
|
| 02/23/2023 |
4
| Litvack Frank (Director) has filed a Form 4 on CAPRICOR THERAPEUTICS, INC.|
Txns:
| Exercised 14,027 shares
@ $1.39, valued at
$19.5k
Paid exercise price by delivering 4,524 shares
@ $4.31, valued at
$19.5k
Exercised 14,027 options to buy
@ $0 |
|
| 01/06/2023 |
4/A
| Sabar Karimah Es (Director) has filed a Form 4 on CAPRICOR THERAPEUTICS, INC.|
Txns:
| Granted 3,560 options to buy
@ $3.85, valued at
$13.7k
|
|
| 01/05/2023 |
4
| Sabar Karimah Es (Director) has filed a Form 4 on CAPRICOR THERAPEUTICS, INC.|
Txns:
| Granted 37,770 options to buy
@ $3.85, valued at
$145.4k
Granted 19,000 options to buy
@ $3.85, valued at
$73.2k
|
|
| 01/05/2023 |
4
| Musket David B (Director) has filed a Form 4 on CAPRICOR THERAPEUTICS, INC.|
Txns:
| Granted 37,770 options to buy
@ $3.85, valued at
$145.4k
Granted 16,620 options to buy
@ $3.85, valued at
$64k
Granted 19,000 options to buy
@ $3.85, valued at
$73.2k
|
|
| 01/05/2023 |
4
| Manzo Louis (Director) has filed a Form 4 on CAPRICOR THERAPEUTICS, INC.|
Txns:
| Granted 37,770 options to buy
@ $3.85, valued at
$145.4k
Granted 7,120 options to buy
@ $3.85, valued at
$27.4k
Granted 19,000 options to buy
@ $3.85, valued at
$73.2k
|
|
|